Syndax Pharmaceuticals (SNDX) Revenue (2016 - 2020)
Historic Revenue for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to $380000.0.
- Syndax Pharmaceuticals' Revenue changed 0.0% to $380000.0 in Q4 2020 from the same period last year, while for Sep 2021 it was $380000.0, marking a year-over-year decrease of 7495.06%. This contributed to the annual value of $23.7 million for FY2024, which is N/A changed from last year.
- As of Q4 2020, Syndax Pharmaceuticals' Revenue stood at $380000.0, which was down 0.0% from $379000.0 recorded in Q3 2020.
- In the past 5 years, Syndax Pharmaceuticals' Revenue ranged from a high of $1.2 million in Q4 2017 and a low of $305000.0 during Q1 2016
- In the last 5 years, Syndax Pharmaceuticals' Revenue had a median value of $379000.0 in 2018 and averaged $393950.0.
- Its Revenue has fluctuated over the past 5 years, first soared by 169411.76% in 2016, then crashed by 6814.75% in 2018.
- Syndax Pharmaceuticals' Revenue (Quarter) stood at $305000.0 in 2016, then skyrocketed by 291.15% to $1.2 million in 2017, then tumbled by 68.15% to $380000.0 in 2018, then changed by 0.0% to $380000.0 in 2019, then changed by 0.0% to $380000.0 in 2020.
- Its Revenue was $380000.0 in Q4 2020, compared to $379000.0 in Q3 2020 and $379000.0 in Q2 2020.